1. Home
  2. RLAY vs AMRC Comparison

RLAY vs AMRC Comparison

Compare RLAY & AMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • AMRC
  • Stock Information
  • Founded
  • RLAY 2015
  • AMRC 2000
  • Country
  • RLAY United States
  • AMRC United States
  • Employees
  • RLAY N/A
  • AMRC N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • AMRC Engineering & Construction
  • Sector
  • RLAY Health Care
  • AMRC Consumer Discretionary
  • Exchange
  • RLAY Nasdaq
  • AMRC Nasdaq
  • Market Cap
  • RLAY 490.3M
  • AMRC 455.0M
  • IPO Year
  • RLAY 2020
  • AMRC 2010
  • Fundamental
  • Price
  • RLAY $3.15
  • AMRC $13.53
  • Analyst Decision
  • RLAY Strong Buy
  • AMRC Buy
  • Analyst Count
  • RLAY 11
  • AMRC 6
  • Target Price
  • RLAY $18.40
  • AMRC $20.17
  • AVG Volume (30 Days)
  • RLAY 2.2M
  • AMRC 625.4K
  • Earning Date
  • RLAY 05-05-2025
  • AMRC 05-05-2025
  • Dividend Yield
  • RLAY N/A
  • AMRC N/A
  • EPS Growth
  • RLAY N/A
  • AMRC N/A
  • EPS
  • RLAY N/A
  • AMRC 1.03
  • Revenue
  • RLAY $7,679,000.00
  • AMRC $1,824,351,000.00
  • Revenue This Year
  • RLAY N/A
  • AMRC $8.31
  • Revenue Next Year
  • RLAY $169.23
  • AMRC $9.81
  • P/E Ratio
  • RLAY N/A
  • AMRC $13.39
  • Revenue Growth
  • RLAY N/A
  • AMRC 30.13
  • 52 Week Low
  • RLAY $1.78
  • AMRC $8.49
  • 52 Week High
  • RLAY $10.72
  • AMRC $39.68
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 50.08
  • AMRC 49.76
  • Support Level
  • RLAY $2.75
  • AMRC $12.95
  • Resistance Level
  • RLAY $3.10
  • AMRC $14.47
  • Average True Range (ATR)
  • RLAY 0.20
  • AMRC 0.74
  • MACD
  • RLAY 0.01
  • AMRC -0.15
  • Stochastic Oscillator
  • RLAY 58.16
  • AMRC 11.89

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About AMRC Ameresco Inc.

Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of its revenue from the U.S. Regions segment.

Share on Social Networks: